THE REIMBURSEMENT OF ORPHAN DRUGS ACROSS EUROPE

被引:0
|
作者
Nixon, F. [1 ]
机构
[1] Heron Evidence Dev Ltd, Letchworth Garden City, England
关键词
D O I
10.1016/S1098-3015(10)66285-7
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A375 / A376
页数:2
相关论文
共 50 条
  • [1] The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe
    Kawalec, Pawel
    Sagan, Anna
    Pilc, Andrzej
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
  • [2] COMPARISON OF TIME TO REIMBURSEMENT RECOMMENDATIONS OF (ORPHAN-) ONCOLOGY DRUGS IN EUROPE
    Nientker, L.
    Trip, A. M.
    Hensen, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S504 - S504
  • [3] The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe
    Paweł Kawalec
    Anna Sagan
    Andrzej Pilc
    [J]. Orphanet Journal of Rare Diseases, 11
  • [4] REIMBURSEMENT DECISION LANDSCAPE FOR ORPHAN DRUGS ACROSS SIX HTA AGENCIES
    Mittal, L. K.
    Banerjee, P.
    Kapoor, A.
    Ligade, V. S.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A257 - A257
  • [5] Pricing and reimbursement of orphan drugs in Italy
    Lopatriello, S.
    Schivazappa, C.
    Negrini, C.
    Berto, P.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A208 - A209
  • [6] REIMBURSEMENT OF ORPHAN DRUGS: WHAT IS THE DIFFERENCE?
    Mueller, E.
    Schmidt, E.
    Ehreth, J.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A311 - A311
  • [7] PRICING AND REIMBURSEMENT OF ORPHAN DRUGS IN CANADA
    Kumar, J.
    Bachman, E. M.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A29 - A29
  • [8] REIMBURSEMENT AND PRICING OF ORPHAN DRUGS IN TAIWAN
    Cheng, C. Y.
    Chan, H. W.
    Fang, C. H.
    [J]. VALUE IN HEALTH, 2019, 22 : S856 - S856
  • [9] Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe
    Krzysztof Piotr Malinowski
    Paweł Kawalec
    Wojciech Trąbka
    Christoph Sowada
    Guenka Petrova
    Manoela Manova
    Alexandra Savova
    Pero Draganić
    Juraj Slabý
    Agnes Männik
    Kristóf Márky
    Zinta Rugaja
    Jolanta Gulbinovic
    Tomas Tesar
    Marian Sorin Paveliu
    [J]. Orphanet Journal of Rare Diseases, 15
  • [10] Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe
    Malinowski, Krzysztof Piotr
    Kawalec, Pawel
    Trabka, Wojciech
    Sowada, Christoph
    Petrova, Guenka
    Manova, Manoela
    Savova, Alexandra
    Draganic, Pero
    Slaby, Juraj
    Mannik, Agnes
    Marky, Kristof
    Rugaja, Zinta
    Gulbinovic, Jolanta
    Tesar, Tomas
    Paveliu, Marian Sorin
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)